Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Klatskin Tumor × Pancreatic Hormones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Klatskin Tumor 1 Carcinoma, Hepatocellular 1

Interventions

Liver Transplantation 4 Capecitabine 4 Radiosurgery 3 Gemcitabine 3 Cisplatin 3 toripalimab 2 Specimen Handling 2 Self Expandable Metallic Stents 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 Fluorouracil 2 trisacryl gelatin microspheres 1 tremelimumab 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 Saline Solution 1 Radiofrequency Ablation 1 Platinum 1 Photosensitizing Agents 1 Photochemotherapy 1 Pancreatic Hormones 1 Optical Imaging 1 Neoadjuvant Therapy 1 N-Ac-CHAVC-NH2 1 Hepatectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06850753 2025-08-21

SURE-LT

Oslo University Hospital

Phase NA Recruiting

Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡